Finasteride, MSD : innovation in the management of benign prostatic hyperplasia : proceedings of a symposium held in Seville, Spain
著者
書誌事項
Finasteride, MSD : innovation in the management of benign prostatic hyperplasia : proceedings of a symposium held in Seville, Spain
（European urology, v. 25 ; Supplement ; 1）
Karger, 1994
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and indexes
内容説明・目次
内容説明
In recent years, significant strides have been made in understanding benign prostatic hyperplasia (BPH) and finding nonsurgical alternatives for its treatment. This volume highlights the current knowledge of the disease process, including papers on the pathophysiology and aetiology of BPH. It also looks at important forms of treatment, in particular the efficacy of Finasteride, a new 5-alpha reductase inhibitor which acts selectively on the prostate and thereby leads to significantly fewer side-effects.
目次
- Pathophysiology of benign prostatic hyperplasia, F. Algaba
- etiology of benign prostatic hyperplasia, J.T. Isaacs
- the natural history of benign prostatic hyperplasia - implications for patient care and clinical trial design, H.A. Guess
- review of current treatment of benign prostatic hyperplasia, T. Hald
- 5-alpha reductase deficiency - human and animal models, J. Imperato-McGinley
- finasteride for the treatment and control of benign prostatic hyperplasia - summary of phase III controlled studies, P. Grino and E. Stoner
- future implications for the management of benign prostatic hyperplasia, L.J. Denis.
「Nielsen BookData」 より
